| lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients H Zou, LX Wu, Y Yang, S Li, Y Mei, YB Liu, L Zhang, Y Cheng, HH Zhou Oncotarget 8 (45), 78767, 2017 | 54 | 2017 |
| RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/β-catenin signaling Y Mei, YB Liu, S Cao, ZW Tian, HH Zhou Cell death & disease 9 (10), 1-17, 2018 | 34 | 2018 |
| Downregulation of RIF1 enhances sensitivity to platinum-based chemotherapy in epithelial ovarian cancer (EOC) by regulating nucleotide excision repair (NER) pathway YB Liu, Y Mei, ZW Tian, J Long, CH Luo, HH Zhou Cellular Physiology and Biochemistry 46 (5), 1971-1984, 2018 | 25 | 2018 |
| RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression YB Liu, Y Mei, J Long, Y Zhang, DL Hu, HH Zhou Journal of Experimental & Clinical Cancer Research 37 (1), 1-15, 2018 | 23 | 2018 |
| Silencing RIF1 decreases cell growth, migration and increases cisplatin sensitivity of human cervical cancer cells Y Mei, C Peng, YB Liu, J Wang, HH Zhou Oncotarget 8 (63), 107044, 2017 | 23 | 2017 |
| Effect of RIF1 on response of non-small-cell lung cancer patients to platinum-based chemotherapy by regulating MYC signaling pathway Y Mei, YB Liu, DL Hu, HH Zhou International Journal of Biological Sciences 14 (13), 1859, 2018 | 16 | 2018 |
| Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer J Long, JY Zhu, YB Liu, K Fu, Y Tian, PY Li, WQ Yang, SY Yang, JY Yin, ... Gynecologic oncology 149 (2), 341-349, 2018 | 15 | 2018 |
| An mRNA vaccine elicits STING-dependent antitumor immune responses Z Chen, C Meng, J Mai, Y Liu, H Li, H Shen Acta Pharmaceutica Sinica B, 2022 | 12 | 2022 |
| 1H NMR based pharmacometabolomics analysis of metabolic phenotype on predicting metabolism characteristics of losartan in healthy volunteers C He, Y Liu, Y Wang, J Tang, Z Tan, X Li, Y Chen, Y Huang, X Chen, ... Journal of Chromatography B 1095, 15-23, 2018 | 12 | 2018 |
| Identification of an Aptamer With Binding Specificity to Tumor-Homing Myeloid-Derived Suppressor Cells. S Tian, T Welte, J Mai, Y Liu, M Ramirez, H Shen Frontiers in pharmacology 12, 752934-752934, 2021 | 2 | 2021 |
| LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy S Mai, A Hodges, HM Chen, J Zhang, YL Wang, Y Liu, F Nakatsu, X Wang, ... Cancer Research 83 (24), 4047-4062, 2023 | 1 | 2023 |
| The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells L Hinkle, Y Liu, C Meng, Z Chen, J Mai, L Zhang, Y Xu, PY Pan, SH Chen, ... The Journal of Immunology 207 (12), 3131-3140, 2021 | 1 | 2021 |
| Amino acid polymer-platinum anticancer drug conjugates H Shen, D Yu, Y Liu US Patent App. 18/265,331, 2024 | | 2024 |
| A porous silicon particle based particulate anti-cancer vaccine for immunotherapy J Mai, Y Liu, D Yu, H Shen Cancer Research 83 (7_Supplement), 6799-6799, 2023 | | 2023 |
| A novel macromolecular platinum drug with potent efficacy to overcome cross-resistance in cancer therapy Y Liu, D Yu, J Mai, PY Pan, SH Chen, H Shen Cancer Research 83 (7_Supplement), 2006-2006, 2023 | | 2023 |
